American Century Companies Inc Catalyst Pharmaceuticals, Inc. Transaction History

American Century Companies Inc

$168 Billion
Q4 2024

A detailed history of American Century Companies Inc transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 157,409 shares of CPRX stock, worth $3.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

157,409

Previous 133,014 18.34%

Holding current value

$3.4 Million

Previous $2.64 Million 24.24%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$19.73 - $23.93 $481,313 - $583,772	24,395 Added 18.34%	157,409 $3.29 Million
Q3 2024 Nov 12, 2024	SELL	$15.19 - $21.35 $564,627 - $793,600	-37,171 Reduced 21.84%	133,014 $2.64 Million
Q2 2024 Aug 07, 2024	SELL	$14.68 - $16.92 $1.39 Million - $1.61 Million	-94,950 Reduced 35.81%	170,185 $2.64 Million
Q1 2024 May 14, 2024	SELL	$13.18 - $17.11 $8.6 Million - $11.2 Million	-652,443 Reduced 71.1%	265,135 $4.23 Million
Q4 2023 Feb 13, 2024	BUY	$11.78 - $17.29 $10.8 Million - $15.9 Million	917,578 New	917,578 $15.4 Million
Q3 2023 Nov 13, 2023	BUY	$11.69 - $15.02 $1.8 Million - $2.31 Million	153,697 Added 20.61%	899,478 $10.5 Million
Q2 2023 Aug 14, 2023	SELL	$11.5 - $18.08 $763,887 - $1.2 Million	-66,425 Reduced 8.18%	745,781 $10 Million
Q1 2023 May 11, 2023	SELL	$14.34 - $21.05 $402,882 - $591,399	-28,095 Reduced 3.34%	812,206 $13.5 Million
Q4 2022 Feb 13, 2023	BUY	$12.25 - $19.5 $981,555 - $1.56 Million	80,127 Added 10.54%	840,301 $15.6 Million
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $905,586 - $1.99 Million	128,270 Added 20.3%	760,174 $9.75 Million
Q2 2022 Aug 12, 2022	BUY	$6.23 - $8.57 $1.79 Million - $2.46 Million	286,556 Added 82.98%	631,904 $4.43 Million
Q1 2022 May 11, 2022	BUY	$5.31 - $8.31 $663,346 - $1.04 Million	124,924 Added 56.67%	345,348 $2.86 Million
Q4 2021 Feb 07, 2022	BUY	$5.21 - $7.45 $278,125 - $397,703	53,383 Added 31.96%	220,424 $1.49 Million
Q3 2021 Nov 10, 2021	BUY	$4.85 - $6.04 $395,260 - $492,241	81,497 Added 95.27%	167,041 $885,000
Q2 2021 Aug 05, 2021	BUY	$4.29 - $6.05 $184,959 - $260,839	43,114 Added 101.61%	85,544 $492,000
Q1 2021 May 14, 2021	BUY	$3.45 - $4.69 $17,356 - $23,595	5,031 Added 13.45%	42,430 $196,000
Q4 2020 Feb 12, 2021	BUY	$2.97 - $3.83 $7,523 - $9,701	2,533 Added 7.26%	37,399 $125,000
Q3 2020 Nov 13, 2020	BUY	$2.97 - $5.08 $47,873 - $81,884	16,119 Added 85.98%	34,866 $104,000
Q2 2020 Aug 13, 2020	BUY	$3.48 - $5.05 $65,239 - $94,672	18,747 New	18,747 $87,000

Others Institutions Holding CPRX

# of Institutions

345

Shares Held

98.4M

Call Options Held

13.4K

Put Options Held

11.7K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.22B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Catalyst Pharmaceuticals, Inc. Transaction History